SPY332.80-2.77 -0.83%
DIA277.19-0.95 -0.34%
IXIC10,782.82-185.53 -1.69%

Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $60

Canaccord Genuity maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $57 to $60.

Benzinga · -

Canaccord Genuity maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $57 to $60.